tiprankstipranks
Advertisement
Advertisement
Risk-Adjusted Buy Rating on Wave Life Sciences: Differentiated Obesity Mechanism, Reset Valuation, and Long-Term Upside Despite 400 mg Uncertainty
PremiumRatingsRisk-Adjusted Buy Rating on Wave Life Sciences: Differentiated Obesity Mechanism, Reset Valuation, and Long-Term Upside Despite 400 mg Uncertainty
12d ago
Wave Life Sciences price target lowered to $39 from $50 at Clear Street
Premium
The Fly
Wave Life Sciences price target lowered to $39 from $50 at Clear Street
12d ago
Wave Life Sciences price target lowered to $25 from $35 at Leerink
Premium
The Fly
Wave Life Sciences price target lowered to $25 from $35 at Leerink
12d ago
Wave Life Sciences falls -57.6%
PremiumThe FlyWave Life Sciences falls -57.6%
12d ago
Wave Life may not be competitive against GLP-1s, says JonesResearch
Premium
The Fly
Wave Life may not be competitive against GLP-1s, says JonesResearch
12d ago
Leerink says Wave Life Sciences selloff ‘very overdone’ after early obesity data
Premium
The Fly
Leerink says Wave Life Sciences selloff ‘very overdone’ after early obesity data
12d ago
Controversial Prasad leaving FDA, NYT reports
PremiumThe FlyControversial Prasad leaving FDA, NYT reports
1M ago
Wave Life Sciences Bets on Data Over Near-Term Revenue
Premium
Company Announcements
Wave Life Sciences Bets on Data Over Near-Term Revenue
1M ago
Wave Life Sciences price target raised to $35 from $33 at Wedbush
Premium
The Fly
Wave Life Sciences price target raised to $35 from $33 at Wedbush
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100